CLINICAL_TRIALS
trial_result
· 2023-06-18
Clinical Trial Update: Treatment of Moderate to Severe Lateral Canthal Lines [Phase 3]
Summary
Phase 3 trial completed for treatment of moderate to severe lateral canthal lines; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Galderma R&D | Conditions: Lateral Canthal Lines | Phase 3 | Status: COMPLETED | Results posted: 2023-06-18